Capital Analysts LLC’s Zimmer Biomet ZBH Stock Holding History

Capital Analysts LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4K	Hold	44	–	–	﹤0.01%	1429
2026 Q1	$4K	Hold	44	–	–	﹤0.01%	1404
2025 Q4	$4K	Hold	44	–	–	﹤0.01%	1375
2025 Q3	$4K	Buy	44 +1	+2%	+$99	﹤0.01%	1343
2025 Q2	$4K	Hold	43	–	–	﹤0.01%	1284
2025 Q1	$5K	Hold	43	–	–	﹤0.01%	1236
2024 Q4	$5K	Hold	43	–	–	﹤0.01%	1161
2024 Q3	$5K	Hold	43	–	–	﹤0.01%	1140
2024 Q2	$5K	Hold	43	–	–	﹤0.01%	1050
2024 Q1	$6K	Hold	43	–	–	﹤0.01%	975
2023 Q4	$5K	Hold	43	–	–	﹤0.01%	969
2023 Q3	$5K	Hold	43	–	–	﹤0.01%	984
2023 Q2	$6K	Hold	43	–	–	﹤0.01%	880
2023 Q1	$6K	Hold	43	–	–	﹤0.01%	856
2022 Q4	$5K	Buy	43 +1	+2%	+$116	﹤0.01%	921
2022 Q3	$4K	Hold	42	–	–	﹤0.01%	931
2022 Q2	$4K	Hold	42	–	–	﹤0.01%	902
2022 Q1	$5K	Sell	42 -1	-2%	-$121	﹤0.01%	830
2021 Q4	$5K	Sell	43 -94	-69%	-$12.3K	﹤0.01%	893
2021 Q3	$19K	Buy	137 +94	+219%	+$13.8K	﹤0.01%	710
2021 Q2	$7K	Sell	43 -94	-69%	-$15.2K	﹤0.01%	793
2021 Q1	$22K	Buy	+137	New	+$21.2K	﹤0.01%	707
2015 Q2	–	Sell	-379	Closed	-$43.2K	–	400
2015 Q1	$43.2K	Hold	379	–	–	0.01%	294
2014 Q4	$41.7K	Hold	379	–	–	0.01%	275
2014 Q3	$37K	Sell	379 -54	-12%	-$5.31K	0.01%	262
2014 Q2	$43.6K	Hold	433	–	–	0.01%	244
2014 Q1	$39.7K	Hold	433	–	–	0.01%	241
2013 Q4	$39.1K	Buy	433 +42	+11%	+$3.63K	0.01%	231
2013 Q3	$31.2K	Buy	+391	New	+$30.8K	0.01%	231

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Analysts LLC's ZBH Position: Q2 2026 in Review

Capital Analysts LLC held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 44 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Capital Analysts LLC first reported a position in ZBH in Q3 2013 and has held it in 29 quarters since. The position peaked at $43.6K in Q2 2014. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Capital Analysts LLC held 44 shares of Zimmer Biomet worth $4K as of Q2 2026.
Capital Analysts LLC left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1429 holding.
Capital Analysts LLC first reported a position in Zimmer Biomet in Q3 2013 and has held it in 29 quarters since.
Capital Analysts LLC's Zimmer Biomet position peaked at $43.6K in Q2 2014.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.